Global & China Nuclear Imaging Systems Market to 2031
Description
China boasts a vast and continually evolving healthcare system, supported by a comprehensive public health insurance framework and a rapidly growing private sector. This intricate procurement environment creates a favorable avenue for investments in advanced medical technologies. The growth of the market is fueled by a strong national commitment to combat the increasing prevalence of chronic diseases, alongside substantial government initiatives aimed at modernizing hospital facilities, particularly with an emphasis on boosting the production of high-quality, domestically produced medical devices.
The country is witnessing a surge in chronic diseases, with the Global Cancer Observatory reporting over 4.8 million new cancer cases in China in 2022. The high cancer incidence underscores the vital importance of nuclear imaging in cancer treatment. Ongoing research continues to affirm the efficacy of nuclear imaging methods across various clinical scenarios. A study published in April 2024 in the journal European Radiology, conducted by researchers from a Chinese university hospital, performed a meta-analysis involving 1,200 patients. The findings revealed that the diagnostic accuracy of fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT scans for a particular type of lung cancer reached 95%, confirming its effectiveness in clinical practice.
The emphasis on indigenous technological innovation and improved domestic manufacturing capabilities offers a significant competitive edge. With ongoing capital investment in infrastructure and a large patient population, the market is well-positioned for further growth.
The country is witnessing a surge in chronic diseases, with the Global Cancer Observatory reporting over 4.8 million new cancer cases in China in 2022. The high cancer incidence underscores the vital importance of nuclear imaging in cancer treatment. Ongoing research continues to affirm the efficacy of nuclear imaging methods across various clinical scenarios. A study published in April 2024 in the journal European Radiology, conducted by researchers from a Chinese university hospital, performed a meta-analysis involving 1,200 patients. The findings revealed that the diagnostic accuracy of fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT scans for a particular type of lung cancer reached 95%, confirming its effectiveness in clinical practice.
The emphasis on indigenous technological innovation and improved domestic manufacturing capabilities offers a significant competitive edge. With ongoing capital investment in infrastructure and a large patient population, the market is well-positioned for further growth.
Table of Contents
107 Pages
- 1. Introduction
- 1.1 Report Guidance
- 1.2 Market Segmentation
- 2. Executive Summary
- 2.1 Key Insights
- 3. Research Methodology
- 3.1 Secondary Research
- 3.2 Primary Research
- 3.2.1 Data Triangulation and Validation:
- 4. China Nuclear Imaging Systems Market Landscape
- 4.1 Overview
- 4.2 Ecosystem Analysis
- 4.2.1 List of Vendors in the Value Chain
- 5. Nuclear Imaging Systems Market Key Market Dynamics
- 5.1 Nuclear Imaging Systems Market – Key Market Dynamics
- 5.2 Market Drivers
- 5.3 Market Restraints
- 5.4 Market Opportunities
- 5.5 Future Trends
- 5.6 Impact of Drivers and Restraints
- 6. China Nuclear Imaging Systems Market – Analysis
- 6.1 China Nuclear Imaging Systems Market Revenue (US$ Million), 2021–2031
- 6.2 China Nuclear Imaging Systems Market Revenue and Forecast Analysis
- 7. China Nuclear Imaging Systems Market Analysis – by Product Type
- 7.1 China Nuclear Imaging Systems Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Product Type
- 8. China Nuclear Imaging Systems Market Analysis – by Application
- 8.1 China Nuclear Imaging Systems Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Application
- 9. China Nuclear Imaging Systems Market Analysis – by End User
- 9.1 China Nuclear Imaging Systems Market – Revenue and Forecast, 2021–2031 (US$ Million) – by End User
- 10. Competitive Landscape
- 10.1 Heat Map Analysis by Key Players
- 10.1 Company Positioning and Concentration
- 11. Industry Landscape
- 11.1 Overview
- 11.2 Market Initiative
- 11.2 Partnerships and Collaborations
- 11.2 Other Developments
- 12. Company Profiles
- 12.1 GE HealthCare Technologies Inc
- 12.1. 1 Key Facts
- 12.1. 2 Business Description
- 12.1. 3 Products and Services
- 12.1. 4 Financial Overview
- 12.1. 5 SWOT Analysis
- 12.1. 6 Key Developments
- 12.2 Siemens Healthineers AG
- 12.2. 1 Key Facts
- 12.2. 2 Business Description
- 12.2. 3 Products and Services
- 12.2. 4 Financial Overview
- 12.2. 5 SWOT Analysis
- 12.2. 6 Key Developments
- 12.3 Canon Inc
- 12.3. 1 Key Facts
- 12.3. 2 Business Description
- 12.3. 3 Products and Services
- 12.3. 4 Financial Overview
- 12.3. 5 SWOT Analysis
- 12.3. 6 Key Developments
- 12.4 Koninklijke Philips NV
- 12.4. 1 Key Facts
- 12.4. 2 Business Description
- 12.4. 3 Products and Services
- 12.4. 4 Financial Overview
- 12.4. 5 SWOT Analysis
- 12.4. 6 Key Developments
- 12.5 Shimadzu Corp
- 12.5. 1 Key Facts
- 12.5. 2 Business Description
- 12.5. 3 Products and Services
- 12.5. 4 Financial Overview
- 12.5. 5 SWOT Analysis
- 12.5. 6 Key Developments
- 12.6 Shanghai United Imaging Healthcare Co., LTD
- 12.6. 1 Key Facts
- 12.6. 2 Business Description
- 12.6. 3 Products and Services
- 12.6. 4 Financial Overview
- 12.6. 5 SWOT Analysis
- 12.6. 6 Key Developments
- 12.7 Neusoft Medical Systems
- 12.7. 1 Key Facts
- 12.7. 2 Business Description
- 12.7. 3 Products and Services
- 12.7. 4 Financial Overview
- 12.7. 5 SWOT Analysis
- 12.7. 6 Key Developments
- 12.8 Mediso Ltd
- 12.8. 1 Key Facts
- 12.8. 2 Business Description
- 12.8. 3 Products and Services
- 12.8. 4 Financial Overview
- 12.8. 5 SWOT Analysis
- 12.8. 6 Key Developments
- 12.9 Positron Corp
- 12.9. 1 Key Facts
- 12.9. 2 Business Description
- 12.9. 3 Products and Services
- 12.9. 4 Financial Overview
- 12.9. 5 SWOT Analysis
- 12.9. 6 Key Developments
- 12.10 MiE GmbH
- 12.10. 1 Key Facts
- 12.10. 2 Business Description
- 12.10. 3 Products and Services
- 12.10. 4 Financial Overview
- 12.10. 5 SWOT Analysis
- 12.10. 6 Key Developments
- 13. Appendix
- 13.1 About Business Market Insights
- 13.2 List of Abbreviations
- TABLE OF TABLES
- Table 1. China Nuclear Imaging Systems Market Segmentation
- Table 2. List of Vendors
- Table 3. China Nuclear Imaging Systems Market – Revenue, 2021–2024 (US$ Million)
- Table 4. China Nuclear Imaging Systems Market – Revenue Forecast, 2025–2031 (US$ Million)
- Table 5. China Nuclear Imaging Systems Market – Revenue, 2021–2024 (US$ Million) – by Product Type
- Table 6. China Nuclear Imaging Systems Market – Revenue Forecast, 2025–2031 (US$ Million) – by Product Type
- Table 7. China Nuclear Imaging Systems Market – Revenue, 2021–2024 (US$ Million) – by Application
- Table 8. China Nuclear Imaging Systems Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
- Table 9. China Nuclear Imaging Systems Market – Revenue, 2021–2024 (US$ Million) – by End User
- Table 10. China Nuclear Imaging Systems Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
- Table 11. List of Abbreviations
- TABLE OF FIGURES
- Figure 1. Impact Analysis of Drivers and Restraints
- Figure 2. China Nuclear Imaging Systems Market Revenue, (US$ Million), 2021–2031
- Figure 3. Heat Map Analysis by Key Players
- Figure 4. Company Positioning and Concentration
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

